Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-03
2005-05-03
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S185000, C514S410000, C514S455000, C514S461000, C604S089000
Reexamination Certificate
active
06887862
ABSTRACT:
A method in which photodynamic therapy is employed to inhibit, stabilize or reduce occlusions within the cardiovascular system by utilizing light within the spectral region of approximately 390 to approximately 610 nm.
REFERENCES:
patent: 5116864 (1992-05-01), March et al.
patent: 5308861 (1994-05-01), Aizawa et al.
patent: 5354774 (1994-10-01), Deckelbaum et al.
patent: 5514707 (1996-05-01), Deckelbaum et al.
patent: 5620438 (1997-04-01), Amplatz et al.
patent: 5833682 (1998-11-01), Amplatz et al.
patent: 5964751 (1999-10-01), Amplatz et al.
patent: 6054449 (2000-04-01), Robinson et al.
patent: 6071944 (2000-06-01), Rodgers et al.
patent: 6132423 (2000-10-01), Aita et al.
patent: WO 0124825 (2001-04-01), None
patent: WO 0124825 (2001-04-01), None
patent: WO 0135997 (2001-05-01), None
patent: WO 0135997 (2001-05-01), None
Isaac Nyamekye, et al., Photodynamic Therapy of Normal and Balloon-Injured Rat Carotid Arteries Using 5-Amino-Levulinic Acid (journal), American Heart Association, Inc., Dec. 15, 1995, pp. 417-425, vol. 91, No. 2.
Motoya Hayase, et al., Photoangioplasty With Local Motexafin Lutetium Delivery Reduces Macrophages in a Rabbit Post-Balloon Injury Model (journal), Cardiovascular Research, 2001, pp. 449-455, vol. 49.
Glenn M. Lamuraglia, et al., Chloroaluminum Sulfonated Phthalocyanine Partitioning in Normal and Intimal Hyperplastic Artery in the Rat, Implications for Photodynamic Therapy (journal), American Journal of Pathology, Dec. 28, 1992, pp. 1898-1905, vol. 142, No. 6.
Yukari Yasunaka, et al., In Vivo Accumulation of Photosensitizers in Atheroslerotic Lesions and Blood in Atherosclerotic Rabbit (journal), Lasers in the Life Sciences, 1991, pp. 53-65.
J. P. Savary, et al., Photodynamic Therapy of Early Squamous Cell Carcinomas of the Esophagus: A Review of 31 Cases (journal), Georg Thieme Verlag Stuttgart, Endoscopy, 1998, pp. 258-265, vol. 30.
J. H. Kinsey, et al, Photodynamic Effect of Hematoporphyrin Derivative as a Function of Optical Spectrum and Incident Energy Density (journal), Cancer Research, Dec. 1981, pp. 5020-5026, vol. 41.
CancerLinksUSA, Cancer Treatment: Photodynamic Therapy (website article), Aug. 24, 1999.
DUSA Pharmaceuticals, Inc/Berlex Laboratories, Inc.,Novel Therapy Receives FDA Approval for Treatment of Common Skin Lesions (website article), 9/27, Publication date not available).
Levulan (registered trademark) Kerastick (registered trademark) (aminolevulinic acid HCl) for Topical Solution, 20% (advertisement), 2000.
G. Michael Vincent, et al., Effects of Benzoporphyrin Derivative Monoacid on Balloon Injured Arteries in a Swine Model of Restenosis (journal), SPIE, pp 72-77, vol. 2671, (publication date not available).
C. A. Waters, et al., Photodymic Therapy with the New Photosensitizer Drug MV6401 Prevents Neointima Formation in Balloon-Injured Rat Carotid Arteries (journal), Supplement to Circulation, Abstracts from Scientific Sessions 2000, Nov. 12, 2000, p 423, vol. 102, No. 18.
I. M. Leitch, et al., Photodymic Therapy with the New Photosensitizer Drug, MV6401, Results in Targeted Cell Death of Neo-Intimal Lesions in Rat Arteries (journal), Supplement to Circulation, Abstracts from the 72nd Scientific Sessions, Nov. 7, 1999, p 247, vol. 100, No. 18.
S. G. Rockson, et al., Photoangioplasty: An Emerging Clinical Cardiovascular Role for Photodynamic Therapy (journal), Circulation, Aug. 1, 2000, pp 591-596, vol. 102.
P. Ortu, et al., Treatment of Arterial Intimal Hyperplasia with Photodymanic Therapy (journal), Photodynamic Therapy and Biomedical Lasers, 1992, pp 225-232.
D. Eton, et al., Inhibition of Intimal Hyperplasia by Photodynamic Therapy Using Photofrin (journal), Journal of Surgical Research, 1992, pp 558-562, vol. 53, No. 6.
M. P. Jenkins, et al., Reduction in the Response to Coronary and Iliac Artery Injury with Photodynamic Therapy Using 5-Aminolaevulinic Acid (journal), Cardiovascular Research, 1999, pp 1-8, 1.
P. Gonschior, et al., Endovascular Catheter-Delivered Photodynamic Therapy in an Experimental Response to Injury Model (journal), Basic Res Cardiol, 1997, pp. 310-319, vol. 92.
G. M. Lamuraglia, et al., Photodynamic Therapy of Vein Grafts: Suppression of Intimal Hyperplasia of the Vein Graft But Not the Anastomosis (journal), Journal of Vascular Surgery, Jun. 1995, vol. 21, No. 6.
G. M. Lamuraglia, et al., Photodynamic Therapy Inhibition of Experimental Intimal Hyperplasia: Acute and Chronic Effects (journal), Journal of Vascular Surgery, 1994, pp. 321-331, vol. 19, No. 2.
Hugh L. Narciso, et al., Retention of Tin Ethyl Etiopurpurin (SnET2) by Atheromatous Plaques: Studies in Vitro & In Vivo Rabbit (journal), SPIE, pp. 30-41, vol. 2130, (publication date not available).
Bryan Cave LLP
Henley III Raymond J.
Miravant Systems, Inc.
LandOfFree
Method for improving treatment selectivity and efficacy... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for improving treatment selectivity and efficacy..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improving treatment selectivity and efficacy... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3441118